Table 3.
a: Factors affecting recurrence-free survival with NMIBC. | |||
---|---|---|---|
Recurrence-free survival |
|||
Prognostic factor | Adjusted HR | 95% CI | p value* |
History of NMIBC | 2.66 | [1.43–4.94] | 0.0019 |
FOXP3/CD8 ratio | 2.11 | [1.15–3.88] | 0.016 |
OX40L overexpression | 2.27 | [1.04–4.97] | 0.0039 |